Literature DB >> 9754708

The role of helper T cell subsets in autoimmune diseases.

J J Lafaille1.   

Abstract

CD4 helper T cells can be divided into Th1 and Th2 subsets based upon the cytokines they produce. Th1 and Th2 cells have been found to be mutually antagonistic, leading to either Th1- or Th2-dominated responses upon immunization. In recent years, several authors have suggested that in chronic inflammatory autoimmune diseases such as diabetes, multiple sclerosis and rheumatoid arthritis, Th1 cells are pathogenic and Th2 cells are protective. Therefore, a successful deviation from a Th1-dominated to a Th2-dominated response could have clinical benefits for individuals suffering from these diseases. Unfortunately, data accumulated over recent years have not supported this approach, in particular regarding the protective role of Th2 cells. In this review we discuss these data and conclude that, at least using currently available tools, immune deviation from Th1 to Th2-dominated responses is ineffective unless started at very early (subclinical) stages of the disease. In addition, we examine some recent data suggesting that, under some circumstances, Th2 cells can be pathogenic.

Entities:  

Mesh:

Year:  1998        PMID: 9754708     DOI: 10.1016/s1359-6101(98)00009-4

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  38 in total

1.  Inhibition of interleukin-12 production by auranofin, an anti-rheumatic gold compound, deviates CD4(+) T cells from the Th1 to the Th2 pathway.

Authors:  T S Kim; B Y Kang; M H Lee; Y K Choe; S Y Hwang
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

2.  Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis.

Authors:  H Jiang; S Curran; E Ruiz-Vazquez; B Liang; R Winchester; L Chess
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-24       Impact factor: 11.205

3.  Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis.

Authors:  Magdalena Janina Laska; Tomasz Brudek; Kari Konstantin Nissen; Tove Christensen; Anné Møller-Larsen; Thor Petersen; Bjørn Andersen Nexø
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 4.  An integrated view of suppressor T cell subsets in immunoregulation.

Authors:  Hong Jiang; Leonard Chess
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

Review 5.  T-cells in Alzheimer's disease.

Authors:  Terrence Town; Jun Tan; Richard A Flavell; Mike Mullan
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 6.  Immunological decision-making: how does the immune system decide to mount a helper T-cell response?

Authors:  Gerard E Kaiko; Jay C Horvat; Kenneth W Beagley; Philip M Hansbro
Journal:  Immunology       Date:  2007-11-05       Impact factor: 7.397

7.  Retinoid-mediated inhibition of interleukin-12 production in mouse macrophages suppresses Th1 cytokine profile in CD4(+) T cells.

Authors:  B Y Kang; S W Chung; S H Kim; S N Kang; Y K Choe; T S Kim
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

8.  All-trans-retinoic acid suppresses interferon-gamma and tumor necrosis factor-alpha; a possible therapeutic agent for rheumatoid arthritis.

Authors:  Yuji Nozaki; Chise Tamaki; Toshiaki Yamagata; Masafumi Sugiyama; Shinya Ikoma; Koji Kinoshita; Masanori Funauchi
Journal:  Rheumatol Int       Date:  2005-11-15       Impact factor: 2.631

9.  Skewed T-cell subsets and enhanced macrophages phagocytosis in the spleen of patients with immune thrombocytopenia failing glucocorticoids.

Authors:  Xiaodong Chen; Sirui Chen; Chunlin Li; Yankun Zhu; Bing Peng
Journal:  Int J Hematol       Date:  2011-08-20       Impact factor: 2.490

10.  Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus.

Authors:  Charles Sia
Journal:  Rev Diabet Stud       Date:  2006-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.